People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Flexus Biosciences, Inc. | — | Biotechnology | Series B | $15.2M | $603.3M | 2013 |
Beth Carlos Seidenberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Beth Carlos Seidenberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Terry Rosen | 1 | 4 |
| Luis Carlos Bayol | 1 | 1 |
| William Carlos Rieflin | 1 | 1 |
| Juan Carlos Jaen | 1 | 1 |
| Dave Carlos Goeddel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.